ATEX 📈 Anterix - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03676C1009

ATEX: Spectrum, Broadband, Networks, Connectivity, Solutions

Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and broadband solutions. It offers CatalyX, a turnkey connectivity management solution platform. The company also holds licensed spectrum in the 900 MHz band with coverage throughout the United States. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey. Web URL: https://www.anterix.com

Additional Sources for ATEX Stock

ATEX Stock Overview

Market Cap in USD 634m
Sector Communication Services
Industry Telecom Services
GiC Sub-Industry Wireless Telecommunication Services
IPO / Inception 2015-02-03

ATEX Stock Ratings

Growth 5y -29.8%
Fundamental -10.3%
Dividend -
Rel. Strength Industry -120
Analysts 4.67/5
Fair Price Momentum 27.57 USD
Fair Price DCF 38.52 USD

ATEX Dividends

No Dividends Paid

ATEX Growth Ratios

Growth Correlation 3m -29.4%
Growth Correlation 12m 28.6%
Growth Correlation 5y -55.6%
CAGR 5y -5.70%
CAGR/Mean DD 5y -0.18
Sharpe Ratio 12m -0.10
Alpha -29.62
Beta 0.79
Volatility 65.43%
Current Volume 166.1k
Average Volume 20d 123.3k
What is the price of ATEX stocks?
As of December 22, 2024, the stock is trading at USD 31.37 with a total of 166,095 shares traded.
Over the past week, the price has changed by -6.39%, over one month by -5.17%, over three months by -20.26% and over the past year by -7.44%.
Is Anterix a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Anterix is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.28 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATEX as of December 2024 is 27.57. This means that ATEX is currently overvalued and has a potential downside of -12.11%.
Is ATEX a buy, sell or hold?
Anterix has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy ATEX.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ATEX stock price target?
According to ValueRays Forecast Model, ATEX Anterix will be worth about 30.4 in December 2025. The stock is currently trading at 31.37. This means that the stock has a potential downside of -2.96%.
Issuer Forecast Upside
Wallstreet Target Price 78.7 150.8%
Analysts Target Price 72 129.5%
ValueRay Target Price 30.4 -3%